SyTrue, Inc., a healthcare data-refinement company, that specializes in natural language processing (NLP) solutions used to translate unstructured medical data into useable clinical information, announced today, a partnership with HighFive, who provides community wide medication management solutions.
Leveraging SyTrue’s NLP OS™ and Semantic terminology server, HighFive has normalized medication data from free text as well as disparate systems into usable interoperable data with assigned RXNORM codes, enabling more robust medication reconciliation and optimization. SyTrue’s terminology server extracts text from any provided medical documents and immediately converts it into the associated RXNORM code.
This solution provides distinct advantages to HighFive customers by providing efficiencies and improved quality. It eliminates the time-consuming step of manually mapping data, thus significantly reducing implementation costs and timeline. SyTrue’s technology enables HighFive to deploy community-wide medication management networks of primary care and specialist practices, free clinics, retail pharmacies, hospitals, behavioral health clinics and skilled nursing facilities in a fraction of the time (and cost) it would take if done any other way.
Strong medication reconciliation and optimization improves adherence
Numerous studies have identified that adverse medication events are at the very core of the readmission problem. This includes patient non-adherence to prescribed drug therapy, which by itself leads to treatment failures and wasted resources costing $150 billion annually. HighFive is now able to provide all healthcare providers and information systems more complete, reconciled medication lists to base care plans around and ultimately improve quality and outcomes.
When a pharmacist has the ability to communicate a richer medication use story including the medication lists from all the patient providers along with medication fill history, better patient care is inevitable. Strong medication reconciliation and optimization improves adherence, outcomes and reduces readmissions and adverse drug events.
“We’re thankful SyTrue has both the expertise and the foresight to produce such catalytic technology to advance the care of populations and community wide medication management. Due to SyTrue, HighFive customer’s can reduce readmissions and unplanned hospitalizations at a justifiable cost.” – Keith Streckenbach, CEO of HighFive